InvestorsHub Logo
Followers 2
Posts 321
Boards Moderated 0
Alias Born 10/09/2017

Re: None

Wednesday, 04/14/2021 9:56:31 AM

Wednesday, April 14, 2021 9:56:31 AM

Post# of 11332
Ongoing profitability a question mark at Organigram

CIBC analyst John Zamparo doesn't see Organigram Holdings (NASDAQ:OGI) returning to positive EBIDTA soon, leading him to cut shares to underperformer and reducing his price target to C$3.25 from C$5.
He says the COVID-19 pandemic will continue to impact its domestic market share while also impacting higher-margin international sales.
Zamparo adds that gross margins will remained depressed through the rest of fiscal 2021 and won't surpass 20% until Q1 fiscal 2022.

https://seekingalpha.com/news/3681677-organigram-cut-on-profitability-concerns-novocure-downgraded-despite-positive-news-and-more-in-todays-analyst-action
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OGI News